Janice Elliott
Primary Care · Uvalde, TXNPI 1922509231
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 37.6% of the total. Reporting peaked in 2024 at $1,216 and has fallen 57.9% since, to $512 in 2025.
Across 101 payments — averaging $27.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AstraZeneca$446
- Bayer$342
- Novo Nordisk$252
- Outset Medical Inc$109
- Lilly USA, LLC$95
- plus $507 from 15 others
What the payments were for
- Food & beverage$2,808100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $1,057 |
| AstraZeneca | 13 | $446 |
| Bayer | 21 | $342 |
| Novo Nordisk | 8 | $252 |
| Outset Medical Inc | 1 | $109 |
| Lilly USA, LLC | 4 | $95 |
| Amgen | 3 | $71 |
| Exact Sciences | 4 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Pfizer | 2 | $44 |
| Alk-abello, Inc | 2 | $44 |
| Cormedix Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Abbott | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Si-bone, Inc. | 1 | $19 |
| GSK | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$741
- AIRSUPRA$246
- AUSTEDO$105
How this compares
$2,808 in reported general payments places this provider in the 85th percentile of 563 primary care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 14 | $1,075 |
| Rosuvastatin Calcium | 15 | $258 |
| Lisinopril | 22 | $98 |
| Metformin Hcl ErMetformin Hcl | 11 | $36 |
| Amlodipine Besylate | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other primary care in Uvalde
- Mary GibbensHouston$42K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Brandi JoynerLongview$12K
- Steven ParisAustin$10K
- Hope OdomCollege Station$10K
- Arlena GraysTomball$9K
- Charlotte BallardSan Antonio$9K
- Hannah LancasterMcKinney$9K
- Jacqueline MilesGrand Prairie$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.